Low Dose Rapamycin in ME/CFS, Long-COVID, and Other Infection Associated Chronic Conditions
Low Dose Rapamycin in ME/CFS, Long-COVID, and Other Infection Associated Chronic Conditions
Enrolling by invitation · NCT06257420 · Registry updated 2026-05-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Low Dose Rapamycin in ME/CFS, Long-COVID, and Other Infection Associated Chronic Conditions | COVID-19, Chronic Disease, Coronaviridae Infections, Disease Attributes, Infections, Neuroinflammatory Diseases, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Post-Infectious Disorders, RNA Virus Infections, encephalomyelitis, long COVID-19, lung disorder, muscle tissue disorder, musculoskeletal system disorder, myalgic encephalomeyelitis/chronic fatigue syndrome, nervous system disorder, neuromuscular disease, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Enrolling by invitation | Not stated | 2026-05-18 | NCT06257420 |
7 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Bateman Horne Center | Salt Lake City | United States | 1 |
| Center For Complex Diseases | Palo Alto | United States | 1 |
| Center For Complex Diseases | Seattle | United States | 1 |
| Sierra Internal Medicine | Incline Village | United States | 1 |
| The Mayo Clinic | Rochester | United States | 2 |